Serum levels of vascular endothelial growth factor and its receptors in patients with severe autism

Clinical Biochemistry

Volumn 43, Issue 3, 2010, Pages 317-319

  Emanuele, Enzo ^a   Orsi, Paolo ^a   Barale, Francesco ^a   di Nemi, Stefania Ucelli ^a   Bertona, Marco ^a   Politi, Pierluigi ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Autism; Enzyme linked immunosorbent assay; Pathophysiology; Vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ADAPTIVE BEHAVIOR; ADULT; ARTICLE; AUTISM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADOLESCENT; ADULT; AUTISTIC DISORDER; BIOLOGICAL MARKERS; FEMALE; HUMANS; MALE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; YOUNG ADULT;

EID: 74249091398     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2009.10.005     Document Type: Article

References (10)

1. Wilcox J., Tsuang M.T., Ledger E., Algeo J., and Schnurr T. Brain perfusion in autism varies with age. Neuropsychobiology 46 (2002) 13-16
2. Burroni L., Orsi A., Monti L., Hayek Y., Rocchi R., and Vattimo A.G. Regional cerebral blood flow in childhood autism: a SPET study with SPM evaluation. Nucl. Med. Commun. 29 (2008) 150-156
3. Gupta S.K., and Ratnam B.V. Cerebral perfusion abnormalities in children with autism and mental retardation: a segmental quantitative SPECT study. Indian Pediatr. 46 (2009) 161-164
4. Yao Y., Walsh W.J., McGinnis W.R., and Praticò D. Altered vascular phenotype in autism: correlation with oxidative stress. Arch. Neurol. 63 (2006) 1161-1164
5. Takahashi H., and Shibuya M. The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. Clin. Sci. (Lond) 109 (2005) 227-241
6. Yasuhara T., Shingo T., and Date I. The potential role of vascular endothelial growth factor in the central nervous system. Rev. Neurosci. 15 (2004) 293-307
7. Fulzele S., and Pillai A. Decreased VEGF mRNA expression in the dorsolateral prefrontal cortex of schizophrenia subjects. Schizophr. Res. 115 (2009) 372-373
8. Balboni G., Pedrabissi L., Molteni M., and Villa S. Discriminant validity of the Vineland scales: score profiles of individuals with mental retardation and a specific disorder. Am. J. Ment. Retard. 106 (2001) 162-172
9. Blumberg H.P., Wang F., Chepenik L.G., Kalmar J.H., Edmiston E., et al. Influence of vascular endothelial growth factor variation on human hippocampus morphology. Biol. Psychiatry 64 (2008) 901-903
10. Nicolson R., DeVito T.J., Vidal C.N., Sui Y., Hayashi K.M., Drost D.J., et al. Detection and mapping of hippocampal abnormalities in autism. Psychiatry Res. 148 (2006) 11-21